Hims & Hers Health, Inc.
Moat Score — Hims & Hers Health, Inc.
Total Moat Score
11 / 30
| Moat Factor | Score | Analysis |
|---|---|---|
| Intangible Assets Patents, trademarks, brand strength, or regulatory licenses that protect a company's products or services from being freely copied by competitors. | 3 / 5 | The HIMS/HERS/H trademarks are recognized consumer health brands and the company holds a large proprietary consultation and outcomes dataset feeding its personalization algorithms, but it holds no drug patents since it sells generics and compounded formulations. |
| Cost Advantage A durable ability to produce goods or services more cheaply than competitors — through scale, unique access to cheap inputs, location, or process — that lets a company undercut rivals or out-earn them at the same price. | 2 / 5 | Owned mail-order pharmacies, a 503B outsourcing facility, and in-house peptide manufacturing lower unit costs versus relying on third-party pharmacy networks, though the underlying telehealth/compounding model is replicable by well-funded competitors. |
| Pricing Power The ability to raise prices without losing meaningful business, because the product or service is differentiated, mission-critical, or has few good substitutes. | 2 / 5 | Subscription pricing is set directly with cash-pay consumers with no insurer intermediation, but the highly competitive DTC telehealth market and low switching costs constrain the company's ability to raise prices without losing subscribers. |
| Network Effect The product or service becomes more valuable to every user as more people or organizations use it, making an established leader harder to displace. | 1 / 5 | The platform connects patients to affiliated providers but does not become more valuable per-user as more people join; there is no meaningful two-sided network effect. |
| Switching Costs The money, time, or operational disruption a customer would face switching to a competitor, which locks in existing customers and supports renewals. | 2 / 5 | Ongoing treatment protocols, refill cadences, and an established provider relationship create some inertia, but subscribers can cancel, snooze, or switch to a competing telehealth platform with minimal friction. |
| Efficient Scale A market that can only profitably support a small number of players, so incumbents face limited threat from new entrants even without other defenses. | 1 / 5 | The DTC telehealth/weight-loss market is large, fast-growing, and attracting many well-capitalized entrants (Ro, Teladoc, pharma-direct channels), so Hims & Hers' scale does not discourage entry. |